CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Net Inc. Y/Y Annual
Select Medical Holdings Corp  (NYSE: SEM)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

SEM's Net Income Growth by Quarter and Year

Select Medical Holdings's Net Income results by quarter and year

 



SEM Net Income (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December - 3.76 61.80 37.71
3rd Quarter September - 81.02 60.82 38.13
2nd Quarter June - 94.77 91.86 66.26
1st Quarter March 74.73 117.17 85.26 55.93
FY   74.73 296.72 299.74 198.03

SEMs Annual Net Income
Select Medical Holdings's Net Income in the fiscal year 2024 $ 296.70 millions
Select Medical Holdings's Net Income in the fiscal year 2023 $ 299.73 millions
Select Medical Holdings's Net Income in the fiscal year 2022 $ 198.03 millions
Select Medical Holdings's Net Income in the fiscal year 2021 $ 0.00 millions
Select Medical Holdings's Net Income in the fiscal year 2020 $ 344.61 millions




SEM Net Income first quarter 2025 Y/Y Growth Comment
Select Medical Holdings Corp reported fall in Net Income in the first quarter 2025 by -36.22% to $ 74.73 millions, from the same quarter in 2024.
The drop in the first quarter 2025 Select Medical Holdings Corp's Net Income compares unfavorably to the Company's average Net Income doubling of 8884.39%.

Looking into first quarter 2025 results within Healthcare Facilities industry 5 other companies have achieved higher Net Income growth. While Select Medical Holdings Corp' s Net Income drop of -36.22% ranks overall at the positon no. 713 in the first quarter 2025.


SEM Net Income ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - -93.92 % 63.88 % -23.04 %
3rd Quarter September - 33.21 % 59.51 % -61.95 %
2nd Quarter June - 3.17 % 38.64 % -
1st Quarter March -36.22 % 37.43 % 52.44 % -
FY   - -1.01 % 51.36 % 32.71 %

Financial Statements
Select Medical Holdings's first quarter 2025 Net Income $ 74.73 millions SEM's Income Statement
Select Medical Holdings's first quarter 2024 Net Income $ 117.17 millions Quarterly SEM's Income Statement


SEM Net Income (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - -95.36 % 1.61 % -1.1 %
3rd Quarter September - -14.51 % -33.79 % -42.45 %
2nd Quarter June - -19.12 % 7.74 % 18.47 %
1st Quarter March 1887.55 % 89.6 % 126.09 % 14.14 %
FY (Year on Year)   - -1.01 % 51.36 % 32.71 %


Compare SEM Profitability >> Back to SEM Growth rate Comparisons >>


Net Income first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #6
Healthcare Sector #56
Overall #713

Net Income Y/Y Growth Statistics
High Average Low
319278.57 % 8884.39 % -99.97 %
(Sep 30 2018)   (Sep 30 2017)
Net Income first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #6
Healthcare Sector #56
Overall #713
Net Income Y/Y Growth Statistics
High Average Low
319278.57 % 8884.39 % -99.97 %
(Sep 30 2018)   (Sep 30 2017)

Net Income by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Select Medical Holdings's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
1889.67 % 57.25 % -100 %
(Mar 31 2025)  


SEM's I. Quarter Q/Q Net Income Comment
Select Medical Holdings Corp achieved in the I. Quarter 2025 above company average sequential Net Income doubling of 1887.55%, to $ 74.73 millions, from $3.76 millions in the fourth quarter.
SEM is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry Select Medical Holdings Corp achieved highest sequential Net Income growth. While Select Medical Holdings's Net Income growth quarter on quarter, overall rank is 19.


Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #3
Overall #19
Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #3
Overall #19
Net Income Q/Q Growth Statistics
High Average Low
1889.67 % 57.25 % -100 %
(Mar 31 2025)  


SEM's I. Quarter Q/Q Net Income Comment
Select Medical Holdings Corp achieved in the I. Quarter 2025 above company average sequential Net Income doubling of 1887.55%, to $ 74.73 millions, from $3.76 millions in the fourth quarter.
SEM is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry Select Medical Holdings Corp achieved highest sequential Net Income growth. While Select Medical Holdings's Net Income growth quarter on quarter, overall rank is 19.


Select Medical Holdings's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)
Cumulative Net Income 12 Months Ending $ 254.27 $ 296.70 $ 354.75 $ 334.55 $ 331.64
Y / Y Net Income Growth (TTM) -23.33 % -1.01 % 28.7 % 32.26 % 45.87 %
Year on Year Net Income Growth Overall Ranking # 346 # 198 # 301 # 435 # 941
Seqeuential Net Income Change (TTM) -14.3 % -16.36 % 6.04 % 0.88 % 10.65 %
Seq. Net Income Growth (TTM) Overall Ranking # 808 # 458 # 527 # 297 # 627


Cumulative Net Income growth Comment
Select Medical Holdings's cumulative 12 months Net Income continue to fall, but on the faster rate at -23.33% year on year, at Mar 31 2025 compare to the -1.01% decrease at Dec 31 2024. If the Select Medical Holdings's fiscal year would end at Mar 31 2025, annual Net Income would be $254 millions.

Within the Healthcare sector 31 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 198 to 346.

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 6
Healthcare Sector # 32
Overall # 346

Net Income TTM Y/Y Growth Statistics
High Average Low
319278.57 %
 8884.39 %
-99.97 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 61
S&P 500 # 808
Cumulative Net Income growth Comment
Select Medical Holdings's cumulative 12 months Net Income continue to fall, but on the faster rate at -23.33% year on year, at Mar 31 2025 compare to the -1.01% decrease at Dec 31 2024. If the Select Medical Holdings's fiscal year would end at Mar 31 2025, annual Net Income would be $254 millions.

Within the Healthcare sector 31 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 198 to 346.


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 6
Healthcare Sector # 32
Overall # 346

Net Income TTM Y/Y Growth Statistics
High Average Low
319278.57 %
8884.39 %
-99.97 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 61
S&P 500 # 808




Other Net Income Growth
Healthcare Facilities Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
SEM's Net Income Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for SEM's Competitors
Net Income Growth for Select Medical Holdings's Suppliers
Net Income Growth for SEM's Customers

You may also want to know
SEM's Annual Growth Rates SEM's Profitability Ratios SEM's Asset Turnover Ratio SEM's Dividend Growth
SEM's Roe SEM's Valuation Ratios SEM's Financial Strength Ratios SEM's Dividend Payout Ratio
SEM's Roa SEM's Inventory Turnover Ratio SEM's Growth Rates SEM's Dividend Comparisons



Companies with similar Net Income fall for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2025
Pfizer Inc-4.80%$ -4.803 millions
Abbvie Inc -6.05%$ -6.050 millions
Incyte Corporation-6.69%$ -6.691 millions
Labcorp Holdings Inc -6.70%$ -6.702 millions
Mettler Toledo International Inc-7.84%$ -7.843 millions
National Research Corporation-9.00%$ -8.995 millions
Progyny Inc -10.88%$ -10.883 millions
Align Technology inc -11.23%$ -11.233 millions
Iqvia Holdings Inc -13.54%$ -13.542 millions
Ani Pharmaceuticals Inc-13.87%$ -13.874 millions
Stryker Corp-17.01%$ -17.005 millions
Embecta Corp -18.69%$ -18.685 millions
West Pharmaceutical Services Inc -22.12%$ -22.116 millions
Utah Medical Products Inc-23.13%$ -23.129 millions
Envista Holdings Corporation-23.73%$ -23.729 millions
Davita Inc -24.11%$ -24.107 millions
Mimedx Group Inc -24.17%$ -24.166 millions
Carlisle Companies Incorporated-25.48%$ -25.481 millions
Corcept Therapeutics Inc-26.26%$ -26.263 millions
Dexcom Inc -28.01%$ -28.005 millions
Insulet Corporation-31.26%$ -31.262 millions
Select Medical Holdings Corp-36.22%$ -36.218 millions
Biogen Inc -38.87%$ -38.866 millions
Alkermes Plc -39.00%$ -39.003 millions
Vertex Pharmaceuticals Inc-41.22%$ -41.224 millions
Amphastar Pharmaceuticals Inc -41.44%$ -41.439 millions
Solventum Corporation-42.19%$ -42.194 millions
Becton Dickinson And Company-42.64%$ -42.644 millions
Lantheus Holdings Inc -44.34%$ -44.345 millions
Pacira Biosciences inc -46.41%$ -46.408 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com